CN111417400B - 氟取代的卟啉化合物、包含其的药物组合物及其制备和使用方法 - Google Patents

氟取代的卟啉化合物、包含其的药物组合物及其制备和使用方法 Download PDF

Info

Publication number
CN111417400B
CN111417400B CN201880077161.7A CN201880077161A CN111417400B CN 111417400 B CN111417400 B CN 111417400B CN 201880077161 A CN201880077161 A CN 201880077161A CN 111417400 B CN111417400 B CN 111417400B
Authority
CN
China
Prior art keywords
subject
ascorbate
radiation
administered
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201880077161.7A
Other languages
English (en)
Chinese (zh)
Other versions
CN111417400A (zh
Inventor
I.巴蒂尼-哈伯勒
A.托夫马斯彦
I.斯帕索耶维奇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Duke University
Original Assignee
Duke University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Duke University filed Critical Duke University
Publication of CN111417400A publication Critical patent/CN111417400A/zh
Application granted granted Critical
Publication of CN111417400B publication Critical patent/CN111417400B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365—Lactones
    • A61K31/375—Ascorbic acid, i.e. vitamin C; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F13/00—Compounds containing elements of Groups 7 or 17 of the Periodic Table
    • C07F13/005—Compounds without a metal-carbon linkage
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
    • A61N2005/1092—Details
    • A61N2005/1094—Shielding, protecting against radiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
CN201880077161.7A 2017-09-29 2018-09-26 氟取代的卟啉化合物、包含其的药物组合物及其制备和使用方法 Active CN111417400B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762565436P 2017-09-29 2017-09-29
US62/565436 2017-09-29
PCT/US2018/052826 WO2019067523A1 (en) 2017-09-29 2018-09-26 FLUOROSUBSTITUTED PORPHYRIN COMPOUNDS, COMPOSITIONS COMPRISING THEM AND METHODS OF PREPARATION AND USE THEREOF

Publications (2)

Publication Number Publication Date
CN111417400A CN111417400A (zh) 2020-07-14
CN111417400B true CN111417400B (zh) 2022-12-02

Family

ID=65903171

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201880077161.7A Active CN111417400B (zh) 2017-09-29 2018-09-26 氟取代的卟啉化合物、包含其的药物组合物及其制备和使用方法

Country Status (8)

Country Link
US (1) US11344574B2 (enExample)
EP (1) EP3687551A4 (enExample)
JP (1) JP7336805B2 (enExample)
KR (1) KR102699638B1 (enExample)
CN (1) CN111417400B (enExample)
CA (1) CA3076008A1 (enExample)
MX (1) MX2020002958A (enExample)
WO (1) WO2019067523A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX394244B (es) 2017-04-04 2025-03-24 Biomimetix Jv Llc Metodos, composiciones, y kits para tratar y/o prevenir un efecto secundario asociado con radiacion y/o exposicion a quimioterapia
EP3687551A4 (en) 2017-09-29 2021-06-23 Duke University FLUORUSUBSTITUTED PORPHYRINE COMPOUNDS, THESE PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR MANUFACTURE AND USE
CN115192705B (zh) * 2021-04-13 2023-10-13 中国科学院化学研究所 一种两性离子共价有机聚合物/二氧化钛纳米复合材料及其制备方法和应用
CN116333037A (zh) * 2021-12-17 2023-06-27 化学与精细化工广东省实验室 含巯基肽与氟代卟啉类偶联用作生物探针

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010080881A1 (en) * 2009-01-07 2010-07-15 Duke University Substituted porphyrins

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2520735B2 (ja) * 1988-07-14 1996-07-31 東洋薄荷工業株式会社 ポルフィリン誘導体
EP1045851B1 (en) 1997-11-03 2003-04-23 Duke University Substituted porphyrins
JPH11217385A (ja) * 1998-01-30 1999-08-10 Nihon Schering Kk 含フッ素ポルフィリン錯体およびそれを含有する造影剤
US6448239B1 (en) 1999-06-03 2002-09-10 Trustees Of Princeton University Peroxynitrite decomposition catalysts and methods of use thereof
US20030050297A1 (en) 2001-01-19 2003-03-13 Crapo James D. Cancer therapy
EP1718201B1 (en) 2004-02-09 2016-09-14 Duke University Substituted porphyrins
BRPI0509359A (pt) * 2004-03-29 2007-09-04 Inotek Pharmaceuticals Corp compostos de porfirina substituìda por piridila e métodos de empregos destes
CN101235036A (zh) 2007-02-02 2008-08-06 济南赛文医药技术有限公司 一类卟啉衍生物及其作为小分子抗氧化剂的应用
GB0819594D0 (en) * 2008-10-24 2008-12-03 Univ Coimbrra Process
WO2015034778A1 (en) 2013-09-03 2015-03-12 Biomimetix J.V., Llc Methods of treating erectile dysfunction
US10080759B2 (en) 2014-01-22 2018-09-25 Duke University Methods of treating pruritus
US10064871B2 (en) 2014-01-22 2018-09-04 Biomimetix Jv, Llc Methods of treating skin disorders
EP3558902A4 (en) * 2016-12-20 2020-06-24 Duke University METHOD FOR PRODUCING PHARMACEUTICAL COMPOUNDS WITH SUBSTITUTED PORPHYRINE AND COMPOSITIONS
WO2018237249A1 (en) 2017-06-22 2018-12-27 Biomimetix Jv, Llc Methods, compositions, and kits for treating inflammatory skin conditions
EP3687551A4 (en) 2017-09-29 2021-06-23 Duke University FLUORUSUBSTITUTED PORPHYRINE COMPOUNDS, THESE PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR MANUFACTURE AND USE

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010080881A1 (en) * 2009-01-07 2010-07-15 Duke University Substituted porphyrins

Also Published As

Publication number Publication date
KR102699638B1 (ko) 2024-08-28
JP7336805B2 (ja) 2023-09-01
CN111417400A (zh) 2020-07-14
US20210361702A1 (en) 2021-11-25
MX2020002958A (es) 2020-08-20
EP3687551A1 (en) 2020-08-05
EP3687551A4 (en) 2021-06-23
US11344574B2 (en) 2022-05-31
CA3076008A1 (en) 2019-04-04
JP2020536055A (ja) 2020-12-10
WO2019067523A1 (en) 2019-04-04
KR20200079237A (ko) 2020-07-02

Similar Documents

Publication Publication Date Title
CN111417400B (zh) 氟取代的卟啉化合物、包含其的药物组合物及其制备和使用方法
JP7753097B2 (ja) Ｈｓｐ９０結合コンジュゲート及びその製剤
TW201034690A (en) Technetium-and rhenium-bis (heteroaryl) complexes and methods of use thereof for inhibiting PSMA
EP2349242B1 (en) Amino acid salts of prostaglandins
AU2022263701A1 (en) Use of medicament in treatment of tumor disease
HUE027711T2 (en) An aqueous formulation of improved stability of (E) -4-carboxystyril-4-chlorobenzylsulfone
US20110275606A1 (en) Substituted porphyrins
EP4349341A1 (en) Pharmaceutical preparation for preventing or treating pulmonary fibrosis
CN104718190B (zh) 用于光动力疗法的吡啶酮化合物
EP2643301A1 (fr) Complexe de technetium 99m en tant qu'outil de diagnostic in vivo des tumeurs cancereuses
US20130225545A1 (en) Porphyrin treatment of neurodegenerative diseases
ES2355784A1 (es) Complejos metalicos mimeticos de sod.
KR20210076041A (ko) 레베르 유전성 시신경병증의 치료 및 예방을 위한 조성물 및 방법
CN112716954B (zh) 氯化两面针碱的药物新用途
CN104321323A (zh) 碳环核苷及其医药用途和组合物
CN116139115A (zh) 厚朴酚和/或和厚朴酚芳环氨基取代类衍生物的抗低氧/缺氧损伤用途及药物组合物
CN111960978A (zh) 一种具有神经保护活性的s-烯丙基-l-半胱氨酸取代酪醇衍生物合成方法及其应用
US20240174608A1 (en) Compounds for brain imaging
US11236056B2 (en) Small molecules and methods of reducing injuries caused by radiation or chemicals
KR20210046115A (ko) 니아신 유도체 및 이를 함유하는 약학 조성물
JP5147825B2 (ja) アンペロプシンの不飽和ナトリウム塩の製剤及びその応用
HK1182933A (en) Compositions, methods and systems for the synthesis and use of imaging agents

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant